The fluoroacetate-producing bacterium Streptomyces cattleya has evolved a fluoroacetyl-CoA thioesterase
(FlK) that exhibits
a remarkably high level of discrimination for its cognate substrate
compared to the cellularly abundant analogue acetyl-CoA, which differs
only by the absence of the fluorine substitution. A major determinant
of FlK specificity derives from its ability to take advantage of the
unique properties of fluorine to enhance the reaction rate, allowing
fluorine discrimination under physiological conditions where both
substrates are likely to be present at saturating concentrations.
Using a combination of pH–rate profiles, pre-steady-state kinetic
experiments, and Taft analysis of wild-type and mutant FlKs with a
set of substrate analogues, we explore the role of fluorine in controlling
the enzyme acylation and deacylation steps. Further analysis of chiral
(R)- and (S)-[2H1]fluoroacetyl-CoA substrates demonstrates that a kinetic isotope
effect (1.7 ± 0.2) is observed for only the (R)-2H1 isomer, indicating that deacylation requires
recognition of the prochiral fluoromethyl group to position the α-carbon
for proton abstraction. Taken together, the selectivity for the fluoroacetyl-CoA
substrate appears to rely not only on the enhanced polarization provided
by the electronegative fluorine substitution but also on molecular
recognition of fluorine in both formation and breakdown of the acyl-enzyme
intermediate to control active site reactivity. These studies provide
insights into the basis of fluorine selectivity in a naturally occurring
enzyme–substrate pair, with implications for drug design and
the development of fluorine-selective biocatalysts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.